AzTrials
AzTrials

Three DimensionalNCT07384338

Three Dimensional Evaluation of Dento-Skeletal Effects of Leaf Self Expander in Cleft Lip and Palate Patients

A study testing Rapid maxillary expansion and Leaf Self Expander in people with Three Dimensional and Dento-Skeletal, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the dento-alveolar changes after maxillary expansion in cleft lip and palate patients by Leaf Self Expander, as compared to conventional Rapid Maxillary Expander using digital cast analysis and three-dimensional cone-beam computed tomography. Read more about this study

Who is it for?
Ages 3 to 24 months
What is being tested?
Rapid maxillary expansion and Leaf Self Expander
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
1 Sep 2023to 1 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 24 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patients with unilateral or bilateral cleft lip and palate in mixed dentition.
  • Lip and palate repair was performed from 3 to 24 months of age.
  • Presence of maxillary constriction and need of maxillary expansion prior to secondary alveolar bone grafting.
  • Good periodontal health.

Who cannot join

  • Previous orthodontic treatments.
  • Any systemic diseases.
  • Multiple carious lesions.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Al-Azhar University

    Cairo, 11651

Other trials in Egypt

About this study

Official title: Three Dimensional Evaluation of Dento-Skeletal Effects of Leaf Self Expander in Cleft Lip and Palate Patients (A Randomized Controlled Clinical Trail)

This study aims to evaluate the dento-alveolar changes after maxillary expansion in cleft lip and palate patients by Leaf Self Expander, as compared to conventional Rapid Maxillary Expander using digital cast analysis and three-dimensional cone-beam computed tomography.

Read the detailed description

Orofacial clefts are the most prevalent among congenital malformations, which can involve the upper lip, alveolar ridge or/and the palate and, in general, cause esthetic, functional, and psychosocial impairments in different magnitudes, depending on its location and extension.

The Leaf Self Expander (LSE) is a new technology that similar to LE in design except absence of the reactivation screw and respects the principle of producing predetermined light, constant forces, without any intervention by the patient, parents or orthodontist. Where it is composed of three leaf springs compressed by the laboratory before delivery, it is deactivated spontaneously until the programmed expansion is achieved.

Being tested
Rapid maxillary expansion, Leaf Self Expander
Medical subject headings
Cleft Lip, Cleft Palate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rapid maxillary expansionOther

    Patients were treated with conventional therapy with rapid maxillary expansion (RME) for maxillary expansion.

  • Leaf Self ExpanderOther

    Patients were treated with Leaf Self Expander for maxillary expansion.

Study groups in NCT07384338
Study groupRoleWhat they receive
Group A (Control group)Active comparatorPatients were treated with conventional therapy with rapid maxillary expansion (RME) for maxillary expansion. Patients were treated with Leaf Self Expander for maxillary expansion.
Receives: Other: Rapid maxillary expansion
Group B (Tested group)ExperimentalPatients were treated with Leaf Self Expander for maxillary expansion.
Receives: Other: Leaf Self Expander

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of linear skeletal change

    Linear skeletal change was assessed to evaluate change in skeletal dimensions following the expansion procedure.

    Measured: 6 months post-expansion

Secondary outcomes (3)
  1. Measurement of angular skeletal change

    Angular skeletal change was assessed to evaluate change in skeletal dimensions following the expansion procedure.

    Measured: 6 months post-expansion

  2. Measurement of linear dental change

    Linear dental change was assessed to evaluate change in tooth position and arch dimensions following the expansion procedure.

    Measured: 6 months post-expansion

  3. Measurement of angular dental change

    Angular dental change was assessed to evaluate change in tooth position and arch dimensions following the expansion procedure.

    Measured: 6 months post-expansion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2026
  2. Study start1 Sep 2023
  3. Primary completion1 Sep 2025
  4. Study completion1 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07384338
Sponsor's protocol ID
P-OR-23-03
Status last verified
Jan 2026
First submitted
21 Jan 2026
Last updated
3 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

A study testing Rapid maxillary expansion and Leaf Self Expander in people with Three Dimensional and Dento-Skeletal, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of linear skeletal change (time frame: 6 months post-expansion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in